The DOI matches its Crossref record.
Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population
Abstract
Adiponectin, which is secreted specifically by adipose tissue, has been shown to act as an anti-atherosclerotic protein by direct effects on endothelial cells. Clinical studies have shown that adiponectin levels are lower in individuals with obesity, diabetes and coronary artery disease. The present study investigated relationships between serum adiponectin levels and body mass index (BMI), blood pressure, insulin resistance index, lipid profile, uric acid and high-sensitivity C-reactive protein levels in a large number of Japanese subjects not taking any medication for metabolic disease and without severe illness (705 men and 262 women; age 30–65 years; BMI 22.5±2.9kg/m2). The serum adiponectin concentration was measured by ELISA, without a protein-denaturing step. The insulin resistance index was assessed by homoeostasis model assessment (HOMA-IR). The serum concentration of adiponectin in women (13.5±7.9μg/ml) was significantly higher than that in men (7.2±4.6μg/ml). The serum adiponectin level was negatively correlated with BMI, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, insulin, HOMA-IR, total cholesterol, triacylglycerols, low-density lipoprotein (LDL)-cholesterol and uric acid, and positively correlated with high-density lipoprotein (HDL)-cholesterol. The correlations between serum adiponectin level and insulin, HOMA-IR, triacylglycerols, HDL-cholesterol, LDL-cholesterol and uric acid were significant even after adjustment for age, sex and BMI. Stepwise multiple regression analysis revealed that HDL-cholesterol, sex, BMI and HOMA-IR were independently correlated with the serum adiponectin level (R2 = 0.377). These findings suggest that the serum adiponectin level is negatively correlated with HOMA-IR and positively correlated with HDL-cholesterol, independent of age, sex and BMI, in the Japanese population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310
The role of the novel adipocyte-derived hormone adiponectin in human disease
Diez, J., & Iglesias, P. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480293 · Cited by 1,114
Adipokines: molecular links between obesity and atheroslcerosis
Lau, D. C. W., Dhillon, B., Yan, H., Szmitko, P. E., & Verma, S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01058.2004 · Cited by 931
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
TRUJILLO, M. E., & SCHERER, P. E. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01426.x · Cited by 769
Adiponectin: action, regulation and association to insulin sensitivity
Lihn, A. S., Pedersen, S. B., & Richelsen, B. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00159.x · Cited by 660
Is visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Adipose Tissue-Derived Factors: Impact on Health and Disease
Trujillo, M. E., & Scherer, P. E. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0033 · Cited by 619
Adiponectin and Breast Cancer Risk
Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D. M., Papadiamantis, Y., Markopoulos, C., Spanos, E., Chrousos, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031804 · Cited by 533
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Wahba, I. M., & Mak, R. H. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04071206 · Cited by 513
Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
Hee Park, K., Zaichenko, L., Brinkoetter, M., Thakkar, B., Sahin-Efe, A., Joung, K. E., Tsoukas, M. A., Geladari, E. V., Huh, J. Y., Dincer, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2373 · Cited by 504
Adiponectin and cancer: a systematic review
Kelesidis, I., Kelesidis, T., & Mantzoros, C. S. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603051 · Cited by 487
Leptin and Cardiovascular Disease: Response to Therapeutic Interventions
Koh, K. K., Park, S. M., & Quon, M. J. (2008) · Circulation · doi:10.1161/circulationaha.107.741645 · Cited by 479
Yanai, H., & Yoshida, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051190 · Cited by 468
Furuhashi, M., Ura, N., Higashiura, K., Murakami, H., Tanaka, M., Moniwa, N., Yoshida, D., & Shimamoto, K. (2003) · Hypertension · doi:10.1161/01.hyp.0000078490.59735.6e · Cited by 461
Gavrila, A., Chan, J. L., Yiannakouris, N., Kontogianni, M., Miller, L. C., Orlova, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030214 · Cited by 441
Baldwin, W., McRae, S., Marek, G., Wymer, D., Pannu, V., Baylis, C., Johnson, R. J., & Sautin, Y. Y. (2011) · Diabetes · doi:10.2337/db10-0916 · Cited by 440
Shetty, G. K., Economides, P. A., Horton, E. S., Mantzoros, C. S., & Veves, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2450 · Cited by 415
Adiponectin and Future Coronary Heart Disease Events Among Men With Type 2 Diabetes
Schulze, M. B., Shai, I., Rimm, E. B., Li, T., Rifai, N., & Hu, F. B. (2005) · Diabetes · doi:10.2337/diabetes.54.2.534 · Cited by 365
Hypoadiponectinemia Is Associated with Impaired Endothelium-Dependent Vasodilation
Tan, K. C. B., Xu, A., Chow, W. S., Lam, M. C. W., Ai, V. H. G., Tam, S. C. F., & Lam, K. S. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031012 · Cited by 360
Daimon, M., Oizumi, T., Saitoh, T., Kameda, W., Hirata, A., Yamaguchi, H., Ohnuma, H., Igarashi, M., Tominaga, M., & Kato, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2015 · Cited by 353
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence
Barb, D., Williams, C. J., Neuwirth, A. K., & Mantzoros, C. S. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.858s · Cited by 338
Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver
Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00431-8 · Cited by 334
Metabolic effects of obesity: A review
Singla, P. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i3.76 · Cited by 326
Lundsgaard, A.-M., & Kiens, B. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00195 · Cited by 289
“Two cross-sectional studies including 1023 and 967 subjects have shown that median serum adiponectin levels were 56 and 88% higher in women than men (64, 65) and in a third study including 182 subjects, plasma adiponectin levels were reported to be 37% higher in women than men (66).”
Age, Obesity, and Sex Effects on Insulin Sensitivity and Skeletal Muscle Mitochondrial Function
Karakelides, H., Irving, B. A., Short, K. R., O'Brien, P., & Nair, K. S. (2010) · Diabetes · doi:10.2337/db09-0591 · Cited by 293
Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer
Tworoger, S. S., Eliassen, A. H., Kelesidis, T., Colditz, G. A., Willett, W. C., Mantzoros, C. S., & Hankinson, S. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1975 · Cited by 284
Adiponectin and Cardiovascular Disease
Han, S. H., Quon, M. J., Kim, J.-A., & Koh, K. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.061 · Cited by 276
Franssen, R., Monajemi, H., Stroes, E. S. G., & Kastelein, J. J. P. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.003 · Cited by 270
Aso, Y., Yamamoto, R., Wakabayashi, S., Uchida, T., Takayanagi, K., Takebayashi, K., Okuno, T., Inoue, T., Node, K., Tobe, T., et al. (2006) · Diabetes · doi:10.2337/db05-1525 · Cited by 264
A Novel Pathway to the Manifestations of Metabolic Syndrome
Sonnenberg, G. E., Krakower, G. R., & Kissebah, A. H. (2004) · Obesity Research · doi:10.1038/oby.2004.24 · Cited by 257
Exercise training is not associated with improved levels of C-reactive protein or adiponectin
Marcell, T. J., McAuley, K. A., Traustadóttir, T., & Reaven, P. D. (2005) · Metabolism · doi:10.1016/j.metabol.2004.11.008 · Cited by 256
Metabolic and Behavioral Characteristics of Metabolically Obese but Normal-Weight Women
Conus, F., Allison, D. B., Rabasa-Lhoret, R., St-Onge, M., St-Pierre, D. H., Tremblay-Lebeau, A., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0265 · Cited by 215
Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function
Stadler, J. T., & Marsche, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238985 · Cited by 200
Nakatani, H., Kasama, K., Oshiro, T., Watanabe, M., Hirose, H., & Itoh, H. (2009) · Metabolism · doi:10.1016/j.metabol.2009.05.006 · Cited by 192
“We [21] and other groups [22,23] have reported that serum adiponectin level was negatively correlated with adiposity variables and insulin resistance.”
BackgroundSelf-citationNew insights into the mechanism of low high-density lipoprotein cholesterol in obesity
Wang, H., & Peng, D.-Q. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-176 · Cited by 140
Hirose, H., Takayama, T., Hozawa, S., Hibi, T., & Saito, I. (2011) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2011.09.005 · Cited by 72
Self-citationDamcott, C. M., Sack, P., & Shuldiner, A. R. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00076-8 · Cited by 63
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Adiponectin and HIV-Lipodystrophy: Taking HAART
Kinlaw, W. B., & Marsh, B. (2004) · Endocrinology · doi:10.1210/en.2003-1513 · Cited by 44
Low levels of adiponectin predict worsening of arterial morphology and function
Störk, S., Bots, M. L., Angerer, P., von Schacky, C., Grobbee, D. E., Angermann, C. E., & Seufert, J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.044 · Cited by 42
Serum adiponectin levels and lifestyle factors in Japanese men
Kotani, K., Sakane, N., Saiga, K., Kato, M., Ishida, K., Kato, Y., & Kurozawa, Y. (2007) · Heart and Vessels · doi:10.1007/s00380-006-0969-2 · Cited by 28
Metadata
- Authors
- YAMAMOTO, Y., HIROSE, H., SAITO, I., TOMITA, M., TANIYAMA, M., MATSUBARA, K., OKAZAKI, Y., ISHII, T., NISHIKAI, K., & SARUTA, T.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2002-07-03
- Volume
- 103
- Issue
- 2
- Pages
- 137-142
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2036767439
- Cited by
- 490
- References
- 0
- FWCI
- 24.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.